AI Verdict
HIMS has stronger fundamentals based on our AI analysis.
HIMS vs HGYN Fundamental Comparison
| Metric | HIMS | HGYN |
|---|---|---|
| Revenue | $2.3B | $612,206.0 |
| Net Income | $128.4M | $116,163.0 |
| Net Margin | 5.5% | 19.0% |
| ROE | 23.7% | N/A |
| ROA | 6.0% | 27.0% |
| Current Ratio | 1.90x | 0.85x |
| Debt/Equity | 0.00x | N/A |
| EPS | $0.51 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HIMS vs HGYN: Frequently Asked Questions
Is HIMS or HGYN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HIMS has stronger fundamentals. HIMS is rated BUY (72% confidence) while HGYN is rated STRONG SELL (90% confidence). This is not investment advice.
How does HIMS compare to HGYN fundamentally?
Hims & Hers Health, Inc. has ROE of 23.7% vs HONG YUAN HOLDING GROUP's N/A. Net margins are 5.5% vs 19.0% respectively.
Which stock pays higher dividends, HIMS or HGYN?
HIMS has a dividend yield of N/A or no dividend while HGYN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HIMS or HGYN for long term?
For long-term investing, consider that HIMS has BUY rating with 72% confidence, while HGYN has STRONG SELL rating with 90% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HIMS vs HGYN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HIMS vs HGYN, the AI consensus favors HIMS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.